首页> 外国专利> glp-1 peptide extended, methods of glp-1 receptor stimulation in an individual requiring blood glucose normalization, treatment of an individual prophylactically for insulin-independent diabetes, reduction or maintenance of body weight, treatment of obesity , and treatment of diseases, in an individual in need thereof, use of a glp-1 compound, process of preparing a pharmaceutical formulation, and, pharmaceutical formulation.

glp-1 peptide extended, methods of glp-1 receptor stimulation in an individual requiring blood glucose normalization, treatment of an individual prophylactically for insulin-independent diabetes, reduction or maintenance of body weight, treatment of obesity , and treatment of diseases, in an individual in need thereof, use of a glp-1 compound, process of preparing a pharmaceutical formulation, and, pharmaceutical formulation.

机译:扩展glp-1肽,刺激需要血糖正常化的个体中的glp-1受体的方法,预防性治疗胰岛素非依赖性糖尿病的个体,减轻或维持体重,肥胖症的治疗以及疾病的治疗有需要的个体,glp-1化合物的用途,制备药物制剂的方法和药物制剂。

摘要

"GLP-1 PEPTIDE EXTENDED, METHODS OF GLP-1 RECEIVER STIMULATION IN AN INDIVIDUAL REQUIRING BLOOD GLUCOSE STANDARDIZATION, PROPHILACY MANAGEMENT OF INDEPENDED DYNAMENTAL BODY MANAGEMENT OBESITY, AND DISEASE TREATMENT, IN AN INDIVIDUAL NEEDING THE SAME, USE OF A GLP-1 COMPOUND, PROCESS FOR PREPARATION OF PHARMACEUTICAL FORMULATION AND FORMULATION ". The present invention includes GLP-I peptides with modifications at various positions attached to an extended C-terminus providing increased stability.
机译:“在单独使用同一剂量的情况下,单独使用Glu-1肽扩展了GLP-1受体刺激的方法,这些方法需要血液葡萄糖的标准化,独立的动力系统肥胖症的易患病管理以及疾病的治疗,这需要单独花费1%药物制剂的制备方法和制剂”。本发明包括GLP-1肽,其在与延伸的C末端连接的多个位置处具有修饰,从而提供增加的稳定性。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号